Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
November 11, 2021
External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data
Pierre Chelle, Dagmar Hajducek, Mohammed Mahdi, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 20, 2019
Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization
Alanna McEneny-King, Pierre Chelle, Gary Foster, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Pediatric Dose Selection for Therapeutic Proteins
Paul R V Malik, Zaid H Temrikar, Pierre Chelle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 3, 2024
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS-Hemo platform
Pierre Chelle, Dagmar Hajducek, Karen Thibaudeau, et al.
Pharmaceutics
|
October 18, 2017
Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis
Alanna McEneny-King, Pierre Chelle, Severine Henrard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 14, 2020
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project
Dagmar M Hajducek, Pierre Chelle, Cedric Hermans, et al.
Hemasphere
|
March 31, 2022
Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
Olav Versloot, Emma Iserman, Pierre Chelle, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 20, 2021
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database
Olav Versloot, Emma Iserman, Pierre Chelle, et al.
Nanoscale
|
January 27, 2018
A method for the quantitative extraction of gold nanoparticles from human bronchoalveolar lavage fluids through a glycerol gradient
Dimitrios Bitounis, Vincent Barnier, Cyril Guibert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 29, 2019
Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients
Pierre Chelle, Aurélie Montmartin, Pauline Damien, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Research and Practice in Thrombosis and Haemostasis
|
November 11, 2021
External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data
Pierre Chelle, Dagmar Hajducek, Mohammed Mahdi, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 20, 2019
Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization
Alanna McEneny-King, Pierre Chelle, Gary Foster, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Pediatric Dose Selection for Therapeutic Proteins
Paul R V Malik, Zaid H Temrikar, Pierre Chelle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 3, 2024
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS-Hemo platform
Pierre Chelle, Dagmar Hajducek, Karen Thibaudeau, et al.
Pharmaceutics
|
October 18, 2017
Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis
Alanna McEneny-King, Pierre Chelle, Severine Henrard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 14, 2020
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project
Dagmar M Hajducek, Pierre Chelle, Cedric Hermans, et al.
Hemasphere
|
March 31, 2022
Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
Olav Versloot, Emma Iserman, Pierre Chelle, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 20, 2021
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database
Olav Versloot, Emma Iserman, Pierre Chelle, et al.
Nanoscale
|
January 27, 2018
A method for the quantitative extraction of gold nanoparticles from human bronchoalveolar lavage fluids through a glycerol gradient
Dimitrios Bitounis, Vincent Barnier, Cyril Guibert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 29, 2019
Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients
Pierre Chelle, Aurélie Montmartin, Pauline Damien, et al.
Page
of 4